We are live on
!
Find out more
PC
Polar Capital Portfolio holdings
AUM
$13.5B
1-Year Est. Return
55.9%
This Fund
S&P 500
This Quarter
Est. Return
-13.72%
1 Year Est. Return
+55.9%
3 Year Est. Return
+127.44%
5 Year Est. Return
+269.08%
10 Year Est. Return
–
AUM
$9.35B
AUM Growth
-$2.4B
(-20%)
Cap. Flow
-$757M
Cap. Flow
% of AUM
-8.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
300
New
33
Increased
109
Reduced
94
Closed
43
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.5M |
| 2 |
Berkshire Hathaway Class B
BRK.B
|
+$62.4M |
| 3 |
Thermo Fisher Scientific
TMO
|
+$53.8M |
| 4 |
Arista Networks
ANET
|
+$47M |
| 5 |
Boston Scientific
BSX
|
+$45.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$112M |
| 2 |
Amgen
AMGN
|
+$102M |
| 3 |
Apple
AAPL
|
+$102M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$72.8M |
| 5 |
Flex
FLEX
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Financials | 23.51% |
| 3 | Healthcare | 21.25% |
| 4 | Communication Services | 7.66% |
| 5 | Consumer Discretionary | 6.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Ascendis Pharma A/S
ASND
$16.6B
| – | – |
-50,000
| Closed | -$3.54M |
|
252
Atara Biotherapeutics
ATRA
$71.2M
| – | – |
-4,000
| Closed | -$4.13M |
|
|
AUTL
253
Autolus Therapeutics
AUTL
$378M
| – | – |
-50,000
| Closed | -$1.53M |
|
254
Avanos Medical
AVNS
| – | – |
-243,104
| Closed | -$16.7M |
|
255
Baxter International
BAX
$12.7B
| – | – |
-800,000
| Closed | -$61.7M |
|
|
BEDU
256
DELISTED
Bright Scholar Education Holdings
BEDU
| – | – |
-7,020
| Closed | -$348K |
|
257
Booking.com
BKNG
$157B
| – | – |
-91,300
| Closed | -$7.25M |
|
258
Pathward Financial
CASH
$1.87B
| – | – |
-109,035
| Closed | -$3M |
|
259
Centene
CNC
$30.7B
| – | – |
-538,076
| Closed | -$39M |
|
260
Cooper Companies
COO
$14.1B
| – | – |
-124,856
| Closed | -$8.65M |
|
261
Cisco
CSCO
$453B
| – | – |
-169,229
| Closed | -$8.23M |
|
262
Encompass Health
EHC
$11.4B
| – | – |
-54,805
| Closed | -$3.4M |
|
|
263
Flex
FLEX
$38.5B
| – | – |
-7,125,173
| Closed | -$70.4M |
|
264
Groupon
GRPN
$1.07B
| – | – |
-50,000
| Closed | -$3.77M |
|
265
ICU Medical
ICUI
$4.14B
| – | – |
-108,312
| Closed | -$30.6M |
|
266
Labcorp
LH
$25.5B
| – | – |
-302,955
| Closed | -$45.2M |
|
267
LivaNova
LIVN
$4.48B
| – | – |
-278,256
| Closed | -$34.5M |
|
268
Eli Lilly
LLY
$1.09T
| – | – |
-81,000
| Closed | -$8.69M |
|
269
Manchester United
MANU
$4.06B
| – | – |
-733,651
| Closed | -$16.5M |
|
270
The Mosaic Company
MOS
$7.19B
| – | – |
-923,529
| Closed | -$30M |
|
271
Neurocrine Biosciences
NBIX
$18.2B
| – | – |
-265,303
| Closed | -$32.6M |
|
272
Protolabs
PRLB
$1.71B
| – | – |
-14,561
| Closed | -$2.35M |
|
273
Ferrari
RACE
$68.2B
| – | – |
-87,070
| Closed | -$13M |
|
274
Transocean
RIG
$5.5B
| – | – |
-1,500,000
| Closed | -$20.9M |
|
275
Supernus Pharmaceuticals
SUPN
$2.71B
| – | – |
-75,000
| Closed | -$3.78M |
|
Similar funds
ECM
FAAS
WAM
FS
NIMC
TI
VIM
PS
Polar Capital's Q4 2018 Portfolio in Review
As of Q4 2018, Polar Capital held 300 positions worth $9.35B, down 20% from $11.8B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Polar Capital withdrew a net $757M in Q4 2018, closing 43 positions and reducing 94 holdings. Its most notable exit was Activision Blizzard, an estimated $72.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Polar Capital opened a new position in Boston Scientific worth $44.2M.
- Polar Capital's largest Q4 2018 buy was Boston Scientific: 1,250,000 shares worth $44.2M.
- Polar Capital added most to Danaher in Q4 2018, an estimated $66.5M increase.
- Polar Capital's biggest Q4 2018 reduction was Merck, cutting an estimated $112M.
- Polar Capital fully exited Activision Blizzard in Q4 2018, selling an estimated $72.8M.
- Polar Capital's ten largest holdings make up 23% of its $9.35B portfolio in Q4 2018.
- Polar Capital opened 33 new positions and closed 43 in Q4 2018.
- Polar Capital's portfolio value fell 20% quarter-over-quarter to $9.35B.
Based on Polar Capital's 13F filing for Q4 2018, filed 14 Feb 2019.